Rating History for MBX Biosciences Inc (MBX) by Oppenheimer
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/4/2026 | Leland Gershell | New Coverage | Outperform (N/A) |
80.00 (N/A) |
29.78 (43.03) |
44.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/4/2026 | Leland Gershell | New Coverage | Outperform (N/A) |
80.00 (N/A) |
29.78 (43.03) |
44.49% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||